CovaSyn Logo
All Articles
Strategy8 min readMarch 10, 2026

Data Governance in Life Sciences: The Underestimated Competitive Advantage

Why data governance for pharma and biotech SMEs is not a luxury but a matter of survival - and how to implement ALCOA+ principles pragmatically.

OK

Oliver Kraft

CovaSyn

Data Governance in Life Sciences: The Underestimated Competitive Advantage

Why Data Governance Belongs on Your Agenda Now

In many life science SMEs, data governance is a topic that gets lost somewhere between IT and quality management. Nobody feels truly responsible, and as long as audits are passed, everything seems fine. But this attitude is becoming increasingly risky - and expensive.

The reality: your data is your most valuable asset. Analytical raw data, batch records, stability data, clinical results - all of this has concrete monetary value. When this data sits in silos, is inconsistent, or isn't traceable, you don't just lose efficiency. You lose competitiveness.

ALCOA+ as a Pragmatic Framework

ALCOA+ is not an academic construct - it's the backbone of any GxP-compliant data strategy. The principles: Attributable, Legible, Contemporaneous, Original, Accurate. The plus stands for Complete, Consistent, Enduring, and Available.

For SMEs, this means concretely: every data point must be attributable to a person or system. Changes must be documented traceably. Data must be captured at the time of creation - not reconstructed later from memory notes.

The Five Most Common Data Governance Gaps in SMEs

First: No clear data ownership. Who is the data owner for your LIMS data? For your ERP master data? If the answer is "IT," you have a problem. Data ownership belongs in the business department.

Second: Paper-based processes alongside digital systems. Hybrid systems - part paper, part digital - are the biggest source of data integrity problems. Every media break is a risk.

Third: No data cataloging. Many SMEs simply don't know what data they have and where. A data catalog isn't a nice-to-have - it's the foundation for any governance strategy.

Fourth: Inadequate audit trail management. Audit trails exist in most systems but are rarely systematically reviewed. An audit trail that nobody reads is worthless.

Fifth: Missing data quality metrics. What you don't measure, you can't improve. Define KPIs for data quality: completeness, consistency, timeliness, accuracy.

Practical Implementation in Three Phases

Phase 1 - Inventory (4-6 weeks): Catalog all data sources. Identify critical data flows. Assess current ALCOA+ maturity per system.

Phase 2 - Governance framework (6-8 weeks): Define data ownership roles. Create data policies and SOPs. Implement data quality metrics and dashboards.

Phase 3 - Continuous improvement (ongoing): Regular data quality reviews. Training program for all employees with data contact. Integration of governance checks into existing quality processes.

The ROI of Data Governance

The investment in data governance pays off multiple times: faster audits through seamless documentation. Fewer deviations through consistent data. Better decisions through reliable data foundations. And not least: a clear competitive advantage in partnerships and licensing negotiations, where data quality is increasingly becoming a deal criterion.

Conclusion

Data governance is not an IT project and not a compliance checkbox. It's a strategic investment that makes the difference between companies that master their data and those that are mastered by their data. Start small, but start now.

CovaSyn MCP

Bring scientific tools into your AI agent.

250+ chemistry, biology, stability, DoE and regulatory functions. Free tier active instantly — no credit card.

Data Governance in Life Sciences: The Underestimated Competitive Advantage - CovaSyn